StockData

Lycia Therapeutics, Inc. (LYCA) stock

LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$30.92
Open
$30.60
Day's range
$30.45 – $32.85
Volume
383,617
Average volume (20 days)
441,424

Lycia Therapeutics stock: common questions

What is Lycia Therapeutics's stock price?

LYCA closed at $31.35 on Nov 18, 2026, up 1.39% on the day.

Does Lycia Therapeutics pay a dividend?

No. Lycia Therapeutics has not paid a cash dividend over the last twelve months.

Who are Lycia Therapeutics's competitors?

Companies most similar to Lycia Therapeutics by business, industry and size include AMGN, GILD, MRNA, BIIB, BNTX.

See a number that looks wrong?